<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Antigen-Based Therapy for the Treatment of Type 1 Diabetes </title>
      <meta name="HW.ad-path" content="/cgi/content/full/58/9/1939" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Antigen-Based Therapy for the Treatment of Type 1 Diabetes"
            name="DC.Title" />
      <meta content="10.2337/db09-0451" name="DC.Identifier" />
      <meta content="2009-09-01" name="DC.Date" />
      <meta content="American Diabetes Association" name="DC.Publisher" />
      <meta content="Jide Tian" name="DC.Contributor" />
      <meta content="Daniel L. Kaufman" name="DC.Contributor" />
      <meta content="Diabetes" name="citation_journal_title" />
      <meta content="0012-1797" name="citation_issn" />
      <meta content="1939-327X" name="citation_issn" />
      <meta content="Tian, Jide; Kaufman, Daniel L." name="citation_authors" />
      <meta content="Antigen-Based Therapy for the Treatment of Type 1 Diabetes"
            name="citation_title" />
      <meta content="09/01/2009" name="citation_date" />
      <meta content="58" name="citation_volume" />
      <meta content="9" name="citation_issue" />
      <meta content="1939" name="citation_firstpage" />
      <meta content="58/9/1939" name="citation_id" />
      <meta content="diabetes;58/9/1939" name="citation_mjid" />
      <meta content="10.2337/db09-0451" name="citation_doi" />
      <meta content="http://diabetes.diabetesjournals.org/content/58/9/1939.full"
            name="citation_fulltext_html_url" />
      <meta content="http://diabetes.diabetesjournals.org/content/58/9/1939.full.pdf"
            name="citation_pdf_url" />
      <meta content="19720821" name="citation_pmid" />
      <meta name="robots" content="noarchive,nofollow" /><script type="text/javascript">
	var podvars;
	if (typeof(podvars) == 'undefined') { podvars = new Object(); }
	podvars["diabetes;58/9/1939"] = new Object();
	podvars["diabetes;58/9/1939"].item_code = "diabetes;58/9/1939/HWP_diabetes";
	podvars["diabetes;58/9/1939"].item_title = "Antigen-Based Therapy for the Treatment of Type 1 Diabetes";
	podvars["diabetes;58/9/1939"].item_category = "ARTICLE";
	podvars["diabetes;58/9/1939"].item_doi = "10.2337/db09-0451";
	
	podvars["diabetes;58/9/1939"].item_authors = "Tian, Jide; Kaufman, Daniel L.";
	podvars["diabetes;58/9/1939"].item_issue_num = "9";
	podvars["diabetes;58/9/1939"].item_volume_num = "58";
	
	podvars["diabetes;58/9/1939"].item_pdf_url = "http://diabetes.diabetesjournals.org/content/58/9/1939.full.pdf+html";
	podvars["diabetes;58/9/1939"].item_starting_page_num = "1939";
	podvars["diabetes;58/9/1939"].item_ending_page_num = "1946";
	podvars["diabetes;58/9/1939"].item_total_page_num = "8";
	podvars["diabetes;58/9/1939"].item_journal_title = "Diabetes";
	</script><link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/standard-designs/design1/main.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all" href="/local/css/local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/standard-designs/design1/leaderboard.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/publisher-leaderboard.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="http://www.diabetesjournals.org/site/css/publisher-custom-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/site/css/journal-custom-global.css" /><script type="text/javascript" id="session-d52894635e1">var callbackToken='561BF5E253709A1';</script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/shared/js/design/hw-design1.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-global.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-sheridanpod.js"></script><script type="text/javascript">
            OAS_sitepage = 'diabetes.diabetesjournals.org'; 
        </script><script type="text/javascript" src="/publisher/js/oas_advertising.js"></script></head>
   <body>
      <div class="hw-gen-page pagetype-content" id="pageid-content">
         <div id="header">
            <img src="/local/img/society_logo.gif" alt="Publisher Logo" id="publisher-main-logo" /><a href="/"><img title="Diabetes" alt="Diabetes" height="75" id="main-logo"
                    src="/local/img/journal_logo.gif" /></a>
            
            <p id="skip-link">
               <a href="#content-block">Skip to main page content</a>
               
            </p>
            
            <ul class="button-list header-buttons">
               <li class="first"><a href="/" title="Home"><span>Home</span></a></li>
               <li><a href="/content/current" title="Current Issue"><span>Current Issue</span></a></li>
               <li><a href="/content" title="Archive"><span>Archive</span></a></li>
               <li><a href="/feedback" title="Contact"><span>Contact</span></a></li>
               <li><a href="/site/subscriptions/" title="Subscribe"><span>Subscribe</span></a></li>
               <li><a href="/cgi/alerts" title="Alerts"><span>Alerts</span></a></li>
               <li class="last"><a href="/help" title="Help"><span>Help</span></a></li>
            </ul>
            
            <div class="header-rss">
               <a href="/rss" class="header-rss"><img src="/shared/img/common/rss.gif" alt="rss feed" /></a>
               
            </div>
            
            <div class="header-qs">
               
               <form class="searchbox" action="/search" method="get">
                  <div>
                     <label for="header-qs-input" id="header-qs-search-label">Search</label><input value="" title="Search Diabetes" type="text" name="fulltext"
                            id="header-qs-input" /><input type="hidden" name="submit" value="yes" /><label for="header-qs-search">GO</label><input value="GO" alt="Link: Go" type="image" id="header-qs-search"
                            src="/shared/img/standard-design/design1/white-dot-arrow.gif" />
                     
                  </div>
               </form>
               
               <div class="adv-search-link"><a href="/search">Advanced Search »</a></div>
               
            </div>
            
            <div class="header-ac-elements">
               
               <div class="inst-branding">
                  
                  
               </div>
               
               <div id="authstring">
                  
                  
               </div>
               
               <div id="hdr-login">
                  
                  <form action="/login" method="post">
                     <div>
                        <label for="hdr-login-username" id="hdr-login-username-label">User Name</label>
                        <input type="text" name="username" id="hdr-login-username" />
                        <label for="hdr-login-password" id="hdr-login-password-label">Password</label>
                        <input type="password" name="code" id="hdr-login-password" />
                        <label for="hdr-login-signin" id="hdr-login-signin-label">
                           Sign In
                           </label>
                        <input value="http://diabetes.diabetesjournals.org/content/58/9/1939.full" name="uri"
                               type="hidden" />
                        <input alt="sign in" value="Sign In" type="image" id="hdr-login-signin"
                               src="/shared/img/standard-design/design1/black-dot-arrow.gif" />
                        
                     </div>
                  </form>
                  
               </div>
               
            </div>
            
            <div class="banner-ads">
               
               <ul>
                  <li class="position-1 no-ad hdr_left"><span>  </span></li>
                  <li class="position-2 no-ad hdr_right"><span>  </span></li>
               </ul>
               
               
            </div>
            
         </div>
         <div id="leaderboard" class="leaderboard-ads">
            <span class="ad-header">
               <a href="http://www.e-healthcaresolutions.com/advertising_contact.php"
                  target="_blank">Advertisement</a>
               	    </span>
            
            <ul>
               <li class="position-top">
                  <script language="JavaScript" type="text/javascript">
                    OAS_AD('Top3');
                </script>
                  </li>
            </ul>
            
            
         </div>
         <div class="leaderboard-clear sb-div"></div>
         <div id="content-block">
            <div class="article fulltext-view">
               <h1 id="article-title-1">Antigen-Based Therapy for the Treatment of Type 1 Diabetes</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li id="contrib-1"><span class="name"><a class="name-search"
                              href="/search?author1=Jide+Tian&amp;sortspec=date&amp;submit=Submit">Jide Tian</a></span> and 
                     </li>
                     <li id="contrib-2"><span class="name"><a class="name-search"
                              href="/search?author1=Daniel+L.+Kaufman&amp;sortspec=date&amp;submit=Submit">Daniel L. Kaufman</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address>From the Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, California.</address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1"><span class="corresp-label"></span>Corresponding author: Daniel L. Kaufman, <span class="em-link"><span class="em-addr">dkaufman{at}mednet.ucla.edu</span></span>.
                     </li>
                  </ol>
               </div>
               <p id="p-2">Antigen-based therapies (ABTs) seek to prevent or inhibit autoimmune diseases by inducing regulatory T-cell responses (active
                  tolerance) or anergizing/deleting pathogenic T-cells (passive tolerance). The theoretical appeal of this therapeutic approach
                  is that it may promote tolerance with little debilitation of the immune system. The clinical application of ABTs for autoimmune
                  disease is still in its infancy. Although initial attempts to apply this therapeutic strategy in multiple sclerosis, rheumatoid
                  arthritis, and type 1 diabetes met with failure, recent results from clinical studies hold promise that this approach may
                  be able to delay the onset of type 1 diabetes as well as preserve β-cell function in latent autoimmune diabetes in adults
                  (LADA) patients and in children newly diagnosed with type 1 diabetes. If verified, it would be an important translation of
                  NOD mouse findings to clinical applications. NOD mouse studies, however, indicate that the immunological impact of ABTs is
                  much more dynamic and complex than previously appreciated. The differences in type 1 diabetes pathogenesis between rodents
                  and humans, as well as other immunotherapeutic approaches, have been extensively reviewed elsewhere (e.g., [<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>–<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>]). Here, we will focus on ABTs and discuss what has been learned about their immunological impact, the theoretical factors
                  affecting their efficacy and safety, as well as potential markers of their therapeutic efficacy.
               </p>
               <div class="section" id="sec-1">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#ack-1" title="Acknowledgments" class="next-section-link"><span>Next Section</span></a></div>
                  
                  
                  
                  <h3>Inflammatory T-cell responses spread among β-cell antigens during the development of murine and human type 1 diabetes.</h3>
                  
                  <p id="p-3">Type 1 diabetes is mediated by autoreactive T-cells recognizing β-cell autoantigens (β-CAAs). In NOD mice, autoreactive CD4<sup>+</sup> T-cells are generally Th1 type (interferonγ secreting), and autoimmunity progressively spreads intra- and intermolecularly
                     among β-CAAs such as insulin, GAD, heat shock protein (HSP), and IGRP during the disease process (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>,<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>). Similarly, spontaneous CD8<sup>+</sup> T-cell responses develop to β-CAAs such as insulin, GAD, IGRP, and others (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>). Paralleling observations in NOD mice, autoreactive Th1-biased CD4<sup>+</sup> and CD8<sup>+</sup> T-cells arise in human type 1 diabetic patients to many of the same β-CAAs (<a id="xref-ref-6-2" class="xref-bibr" href="#ref-6">6</a>–<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>). This spreading of inflammatory T-cell responses creates a proinflammatory cascade, driving disease progression (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>).
                  </p>
                  
                  
                  
                  <h3>ABT-induced active tolerance.</h3>
                  
                  <p id="p-4">Autoantigen administration in modes that induce regulatory T-cell responses such as Th2 (secreting interleukin [IL]-4 and
                     IL-5), Th3 (secreting TGFβ), Tr1 (secreting IL-10), and CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Treg (secreting IL-10 and TGFβ) can inhibit proinflammatory Th1 and Th17 responses and prevent disease in animal models of
                     type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and uveitis. This induction of active tolerance does not require
                     information regarding the initiating target antigen or the specificity of effector T-cells. When therapy-induced regulatory
                     T-cells encounter the antigen at sites of inflammation, they release anti-inflammatory cytokines, which locally suppress effector
                     T-cells regardless of their specificity in a process termed bystander suppression (<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>). Even though inflammatory autoreactive T-cell responses persist, ABT-induced regulatory responses can establish a tissue-specific
                     long-term functional tolerance without debilitating immune competence.
                  </p>
                  
                  <p id="p-5">ABTs not only induce regulatory responses to the administered autoantigen, they also promote the spreading of regulatory responses
                     to other target tissue autoantigens (<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>). For example, NOD mice treated with a single β-CAA in incomplete Freund's adjuvant (IFA, a Th2-promoting adjuvant) developed
                     Th2 responses to the injected autoantigen as well as all the other tested β-CAAs (<a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>). This spreading of regulatory responses is limited to β-CAA target determinants and does not occur in wild-type mice (<a id="xref-ref-13-3" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>). ABT-induced Tr1 and Treg responses have also been observed to spread in the experimental autoimmune encephalomyelitis (EAE)
                     model and after organ transplantation (<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>). Thus, like inflammatory responses, regulatory T-cell responses can spread, presumably through their secretion of cytokines
                     and their effects on antigen-presenting cells (APCs) that promote the activation/expansion of similar T-cell responses (<a id="xref-ref-13-4" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-15-2" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>–<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>).
                  </p>
                  
                  <p id="p-6">This ABT-induced spreading of regulatory responses can be very broad and rapid. For example, when neonatal NOD mice were immunized
                     with a single β-CAA in IFA, splenic Th2-type cell autoimmunity arose precociously to every tested β-CAA by the time the mice
                     were 4 weeks old, which is much sooner than when autoreactivity to these β-CAAs becomes detectable in unmanipulated NOD mice
                     (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>). Evidently, prior to the onset of insulitis NOD mice have a broad array of β-CAA–reactive T-cells that can quickly activate
                     and/or expand when sufficient costimulatory signals are provided. Because Th2 responses spread to every tested β-CAA target
                     determinant, the number of regulatory T-cell responses resulting from spreading may far outnumber those primed to the administered
                     β-CAA itself.
                  </p>
                  
                  <p id="p-7">Besides increasing bystander suppression, the spreading of regulatory T-cell responses can exhaust naïve autoantigen-specific
                     T-cell pools that could be recruited into the pathogenic response (<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>). Moreover, their anti-inflammatory cytokines can educate and modulate APCs into tolerogenic APCs, which can further promote
                     regulatory T-cell responses (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>–<a id="xref-ref-20-2" class="xref-bibr" href="#ref-20">20</a>). These coinciding effects may underlie the protective effects of ABT.
                  </p>
                  
                  
                  
                  <h3>Factors affecting the efficacy of ABTs in NOD mice</h3>
                  
                  
                  <h4>Size matters.</h4>
                  
                  <p id="p-8">A small antigen may contain only one determinant that is presented only by a particular major histocompatability complex,
                     whereas a large protein contains many determinants presented by each major histocompatability complex allele product. Accordingly,
                     the size of the autoantigen used in ABTs affects the magnitude of induced T-cell responses. Indeed, GAD but not insulin B-chain
                     or HSPp277 vaccination prolonged syngenic islet graft survival in diabetic NOD mice (<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>), and treatment with a combination of GAD peptides prevented disease more effectively in NOD mice than the individual peptides
                     (<a id="xref-ref-14-2" class="xref-bibr" href="#ref-14">14</a>).
                  </p>
                  
                  
                  
                  <h4>Antigen expression pattern.</h4>
                  
                  <p id="p-9">Each self-protein has a unique expression pattern leading to differences in central and peripheral tolerance induction and
                     the number and avidity of antigen-specific (cognate) T-cells remaining in the repertoire (<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a>). In humans, the expression level of proinsulin in the thymus is regulated by allelic variations that are linked with type
                     1 diabetes susceptibility (<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>). In NOD mice, proinsulin 2, but not proinsulin 1, is expressed in the thymus, and knocking out proinsulin 2 expression accelerates
                     their disease process (<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>). Whether the GAD65 gene is transcribed in the NOD mouse thymus is controversial, and there is no detectable GAD enzymatic
                     activity in their thymus (D.L.K., unpublished data). GADs are fairly rare proteins in neurons, and although GAD65 is expressed
                     at very low levels in mouse β-cells (<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>), it is sufficient to allow a GAD65-specific CD8<sup>+</sup> T-cell clone to rapidly destroy β-cells in NOD/scid mice (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>). The low expression of GAD in tissues may underlie the large high-avidity repertoire of naïve GAD65-reactive T-cells in
                     preautoimmune NOD mice, which is indicative of little negative selection (<a id="xref-ref-11-2" class="xref-bibr" href="#ref-11">11</a>). The size and avidity of naïve antigen-specific T-cell pools determines in large part the ability of that antigen to prime
                     regulatory responses (<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>).
                  </p>
                  
                  
                  
                  <h4>Stage of the disease process.</h4>
                  
                  <p id="p-10">Although ABTs can be highly effective when administered early in the NOD mouse disease process, they become less effective
                     as the autoimmune process progresses. The ability of foreign antigens and non–β-cell self-antigens to induce immune responses
                     in NOD mice is unaffected by their disease process (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Fig. 1</a><em>A</em>) (<a id="xref-ref-22-2" class="xref-bibr" href="#ref-22">22</a>,<a id="xref-ref-28-2" class="xref-bibr" href="#ref-28">28</a>). In contrast, there is a dramatic decline in the ability of whole β-CAAs and peptides containing β-CAA target determinants
                     to prime Th2 immunity and Th2 spreading with disease progression (<a id="xref-fig-1-2" class="xref-fig" href="#F1">Fig. 1</a><em>B</em>) (<a id="xref-ref-22-3" class="xref-bibr" href="#ref-22">22</a>,<a id="xref-ref-28-3" class="xref-bibr" href="#ref-28">28</a>). This attenuation in the ability of β-CAAs to induce regulatory responses is likely to reflect the progressive recruitment
                     of naïve β-CAA–reactive T-cells into the pathogenic response, which reduces the availability of naïve cognate T-cells that
                     can be primed by ABT.
                  </p>
                  
                  <div id="F1" class="fig pos-float">
                     <div class="fig-inline"><a href="1939/F1.expansion.html"><img alt="FIG. 1." src="1939/F1.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="1939/F1.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="1939/F1.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services"></ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label">FIG. 1.</span> 
                        
                        <p id="p-11" class="first-child">The ability of target determinants but not ignored determinants to induce Th2 responses attenuates with disease progression
                           in NOD mice. NOD mice were immunized either at 6 or 12 weeks of age with a peptide containing a control immunogenic foreign
                           (hen egg lysozyme [HEL]) or a self-determinant (mouse serum albumin [MSA]) (<em>A</em>), a major target determinant of a β-CAA (<em>B</em>), or an absolute cryptic determinant from within GAD or from within other β-cell antigens that are completely ignored by
                           the autoimmune response (islet amyloid polypeptide [IAPP], reduced expression in cancer [REC], or calbindin [CALB]) (<em>C</em>) in IFA. Subsequently, the frequency of IL-4–secreting splenic T-cells responding to the injected antigen was determined
                           by enzyme-linked immunosorbent spot. Data shown is the mean number of IL-4–secreting spot-forming colonies (SFC). Details
                           about the ignored determinants are provided in (<a id="xref-ref-28-4" class="xref-bibr" href="#ref-28">28</a>).
                        </p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  <p id="p-12">After NOD mice develop mild hyperglycemia, ABTs have little ability to slow disease progression. NOD mice often progress from
                     mild to severe hyperglycemia within 1–2 weeks, but it takes about 10–14 days for ABTs to induce maximal immune responses to
                     the administered β-CAA and longer for regulatory T-cell responses to spread to other β-CAAs. By the time ABT-induced regulatory
                     responses peak, insufficient β-cell mass remains. In contrast, anti-CD3 and other systemic immunosuppressants have an immediate
                     effect and can reverse hyperglycemia in newly diabetic NOD mice (<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>). Even with anti-CD3 treatment, however, NOD mice must be treated before their blood glucose exceeds 400 mg/dl to be effective
                     (<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>). This suggests that sufficient residual β-cell mass is required for the treatment to be beneficial, a notion supported by
                     results from clinical trials with anti-CD3 and GAD vaccination (<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a>,<a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a>).
                  </p>
                  
                  <p id="p-13">Although ABTs do not efficiently reverse hyperglycemia in NOD mice, ABTs can induce potent regulatory responses after type
                     1 diabetes onset, evidenced by the ability of ABTs to prolong the survival of syngenic islet grafts in NOD mice (<a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">23</a>,<a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a>). In these studies, diabetic NOD mice were given ABT, maintained on insulin, and implanted several weeks later with syngenic
                     islets, thereby allowing sufficient time for the induction of regulatory responses. Vaccination with GAD, but not insulin
                     B-chain or HSPp277, prolonged islet graft survival (<a id="xref-ref-23-3" class="xref-bibr" href="#ref-23">23</a>). This may reflect GAD's larger size and numerous immunogenic determinants as well as greater immunogenicity in NOD mice
                     with advanced disease (<a id="xref-ref-22-4" class="xref-bibr" href="#ref-22">22</a>). Additionally, the size of the ABT-induced CD4<sup>+</sup>CD25<sup>+</sup> Treg response was an important factor (<a id="xref-ref-33-2" class="xref-bibr" href="#ref-33">33</a>). These findings suggest that late in the disease process, regulatory responses may be best elicited with target tissue antigens
                     that have large pools of uncommitted cognate T-cells available for priming.
                  </p>
                  
                  
                  
                  <h4>Targeted versus ignored β-cell antigens.</h4>
                  
                  <p id="p-14">ABTs have focused on administering the autoantigens themselves. However, because the ability of β-CAAs to prime immune responses
                     attenuates with disease progression, β-cell antigens that are completely uninvolved in the autoimmune process can, depending
                     on their immunogenicity, prevent disease more effectively in NOD mice with an advanced disease process (<a id="xref-fig-1-3" class="xref-fig" href="#F1">Figs. 1</a>–<a id="xref-fig-3-1" class="xref-fig" href="#F3">3</a>; [<a id="xref-ref-28-5" class="xref-bibr" href="#ref-28">28</a>]). Such ABT-induced neoautoimmunity, however, may have unforeseen dangers. Likewise, the immunogenicity of synthetic peptides
                     containing β-CAA target determinants attenuates, but the immunogenicity of determinants within the same β-CAA that are ignored
                     by the autoimmune process (i.e., absolute cryptic determinants; <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a>; [<a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">34</a>,<a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a>]) is unaffected by disease progression (<a id="xref-fig-1-4" class="xref-fig" href="#F1">Fig. 1</a><em>C</em>; [<a id="xref-ref-28-6" class="xref-bibr" href="#ref-28">28</a>]). Because absolute cryptic determinants are poorly presented from whole antigen and have had little impact on T-cell selection,
                     there are large pools of cognate T-cells available for priming late in the disease process by treatment with a synthetic peptide
                     containing the determinant (which bypasses whole antigen processing) (<a id="xref-ref-10-3" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-34-2" class="xref-bibr" href="#ref-34">34</a>,<a id="xref-ref-35-2" class="xref-bibr" href="#ref-35">35</a>). Vaccination of 12-week-old NOD mice with absolute cryptic determinants primed stronger regulatory T-cell responses and
                     prevented type 1 diabetes more effectively than vaccination with the major target determinants of β-CAAs (<a id="xref-fig-1-5" class="xref-fig" href="#F1">Figs. 1</a> and <a id="xref-fig-2-2" class="xref-fig" href="#F2">2</a>). The immunogenicity of targeted and ignored determinants as well as the magnitude of induced Th2 responses were positively
                     correlated with their ability to prevent type 1 diabetes in NOD mice (<a id="xref-fig-3-2" class="xref-fig" href="#F3">Fig. 3</a>; [<a id="xref-ref-28-7" class="xref-bibr" href="#ref-28">28</a>]). These observations suggest that fragmenting a large autoantigen (e.g., by endopeptidases or by using a set of synthetic
                     peptides) may expose many cryptic determinants and prime more regulatory responses than whole autoantigen. Inducing regulatory
                     responses to absolute cryptic β-CAA determinants may be safe because <em>1</em>) regulatory autoreactivity spreads only to β-CAA target determinants, like what occurs after traditional ABTs (<a id="xref-ref-15-3" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-28-8" class="xref-bibr" href="#ref-28">28</a>), and <em>2</em>) it is less likely to boost pathogenic T-cell responses because cognate T-cells are not already activated in vivo. In the
                     cancer vaccine field, immunization with cryptic determinants can elicit larger and higher-avidity T-cell responses than tumor
                     antigen–dominant determinants in mice, and clinical trials using cryptic tumor antigen determinants are in progress (<a id="xref-ref-35-3" class="xref-bibr" href="#ref-35">35</a>,<a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a>).
                  </p>
                  
                  <div id="F2" class="fig pos-float">
                     <div class="fig-inline"><a href="1939/F2.expansion.html"><img alt="FIG. 2." src="1939/F2.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="1939/F2.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="1939/F2.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services"></ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label">FIG. 2.</span> 
                        
                        <p id="p-15" class="first-child">Type 1 diabetes incidence in NOD mice immunized with a control (<em>A</em>), target (<em>B</em>), or ignored (<em>C</em>) antigen. Mice were immunized at 12 weeks of age with the indicated antigen. *<em>P</em> &lt; 0.05 and **<em>P</em> &lt; 0.01 relative to the unmanipulated NOD mouse group. (Details are provided in ref. <a id="xref-ref-28-9" class="xref-bibr" href="#ref-28">28</a>). CALB, calbindin; IAPP, islet amyloid polypeptide; MSA, mouse serum albumin; REC, reduced expression in cancer.
                        </p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  <div id="F3" class="fig pos-float">
                     <div class="fig-inline"><a href="1939/F3.expansion.html"><img alt="FIG. 3." src="1939/F3.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="1939/F3.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="1939/F3.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services"></ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label">FIG. 3.</span> 
                        
                        <p id="p-16" class="first-child">Correlation between a β-CAA's ability to prime responses in NOD mice and its therapeutic efficacy. <em>A</em>: Correlation between a β-CAA ignored determinant's immunogenicity (as determined in ref. <a id="xref-ref-28-10" class="xref-bibr" href="#ref-28">28</a>) and its therapeutic efficacy (type 1 diabetes incidence at 45 weeks in <a id="xref-fig-2-3" class="xref-fig" href="#F2">Fig. 2</a>) (<em>R</em> = 0.87; <em>P</em> = 0.02). <em>B</em>: Correlation between the ability of a target or an ignored determinant to prime IL-4–secreting Th2 responses at 12 weeks
                           of age and its therapeutic efficacy (<em>R</em> = 0.86; <em>P</em> = 0.002). (Details are provided in ref. <a id="xref-ref-28-11" class="xref-bibr" href="#ref-28">28</a>). SFC, spot-forming colonies; T1D, type 1 diabetes.
                        </p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  <div class="table pos-float" id="T1">
                     <div class="table-inline">
                        <div class="callout"><span>View this table:</span><ul class="callout-links">
                              <li><a href="1939/T1.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="1939/T1.expansion.html">In a new window</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="table-caption"><span class="table-label">TABLE 1</span> 
                        
                        <p id="p-17" class="first-child">Glossary</p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  
                  
                  <h4>Prior immunological history affects subsequent immune responses.</h4>
                  
                  <p id="p-18">In mice, preexisting Th1 responses can modify subsequent immune responses to another antigen administered in a Th2-promoting
                     adjuvant (<a id="xref-ref-20-3" class="xref-bibr" href="#ref-20">20</a>). This modulation may be due to cytokines produced by the first wave of effector and memory cells or by education of APCs
                     (<a id="xref-ref-19-3" class="xref-bibr" href="#ref-19">19</a>,<a id="xref-ref-20-4" class="xref-bibr" href="#ref-20">20</a>). Children vaccinated with Bacillus Calmette-Guerin have reduced incidence of atopic disease, indicating that an individual's
                     prior immune responses influence subsequent responses (<a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a>). Interestingly, GAD/alum vaccination (20 μg) did not boost GAD autoantibodies in LADA patients who have a slowly progressing
                     form of type 1 diabetes (<a id="xref-table-wrap-1-2" class="xref-table" href="#T1">Table 1</a>), but greatly increased GAD autoantibodies in newly diabetic children, suggesting that the aggressiveness of an autoimmune
                     response influences immune responses to ABT (see below). If preexisting autoimmune responses modulate ABT-induced responses,
                     it may be beneficial to reduce pathogenic responses prior to ABT, to coadminister factors (e.g., cytokines) that will help
                     enforce the induction of regulatory responses, and to optimize ABT dose and frequency for different stages of the autoimmune
                     process.
                  </p>
                  
                  
                  
                  <h4>ABT dose and route.</h4>
                  
                  <p id="p-19">The subcutaneous administration of soluble self-antigen is generally only weakly immunogenic, but repeated treatments can
                     prime regulatory responses (<a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a>,<a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39</a>). Mucosal delivery favors the generation of regulatory responses (<a id="xref-ref-12-2" class="xref-bibr" href="#ref-12">12</a>,<a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">40</a>). Inhalation of antigen induces regulatory T-cell responses more effectively than delivering the antigen orally. The most
                     efficient way to induce robust responses to self-antigens is to deliver them in adjuvants. Immunization with adjuvant provides
                     a depot of antigen that can promote tolerogenic T-cells and APC<em>s</em> long-term in vivo. However, a more robust immune response has the inherent danger of inducing more undesired responses.
                  </p>
                  
                  <p id="p-20">DNA vectors that express a β-CAA are stable and can codeliver other genes encoding immune-modulating proteins. Since CpG motifs
                     in DNA act as proinflammatory adjuvants by binding to a Toll-like receptor, codelivery of immunoregulatory genes may be necessary
                     to drive functionally dominant regulatory responses (e.g., [<a id="xref-ref-33-3" class="xref-bibr" href="#ref-33">33</a>]).
                  </p>
                  
                  <p id="p-21">The effect of ABT dose and frequency in humans with ongoing autoimmunity is only beginning to be studied and remains a key
                     issue for developing ABTs. We should presume that ABTs will evoke a mixture of immune responses including inducing regulatory
                     T-cells, boosting pathogenic responses, and causing T-cell exhaustion, anergy, and deletion. The extent of each of these responses
                     may depend on the dose, route, and frequency of treatment. Such mixed responses to ABT may explain why different dosages of
                     oral insulin gave variable results in a small clinical trial with new-onset type 1 diabetic patients (<a id="xref-ref-41-1" class="xref-bibr" href="#ref-41">41</a>), why the beneficial effect of GAD/alum vaccination in LADA patients was confined to a particular dose and did not display
                     dose dependency (<a id="xref-ref-42-1" class="xref-bibr" href="#ref-42">42</a>), and why GAD/alum-treated new-onset type 1 diabetic patients displayed a very diverse array of cytokine responses to GAD
                     ([<a id="xref-ref-32-2" class="xref-bibr" href="#ref-32">32</a>], see below).
                  </p>
                  
                  
                  
                  
                  <h3>Passive tolerance.</h3>
                  
                  <p id="p-22">ABTs can induce passive tolerance by anergizing/deleting autoreactive T-cells. Passive tolerance can also be created in transgenic
                     animals by suppressing autoantigen expression or by eliminating target determinants from an autoantigen. Passive tolerance
                     to insulin (<a id="xref-ref-43-1" class="xref-bibr" href="#ref-43">43</a>,<a id="xref-ref-44-1" class="xref-bibr" href="#ref-44">44</a>) and GAD (<a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>,<a id="xref-ref-45-1" class="xref-bibr" href="#ref-45">45</a>) in NOD mice prevents the development of insulitis and type 1 diabetes. These observations may define primary β-cell autoantigen(s)
                     or point to autoreactivities that are necessary drivers of the autoimmune response without which other nascent autoreactivities
                     succumb to activation-induced cell death or regulation. Transgenic NOD mice that are largely, but incompletely, passively
                     tolerized to GAD (<a id="xref-ref-46-1" class="xref-bibr" href="#ref-46">46</a>) initially have a broad reduction in T-cell responses to other β-CAAs, indicating that early T-cell autoreactivities require
                     mutual support for expansion (J.T., D.L.K., unpublished data). As the mice grow older, however, they develop supernormal T-cell
                     responses to other β-CAAs, such that disease incidence is unabated. Thus, deleting/anergizing many GAD-reactive T-cells allowed
                     other β-CAA–reactive T-cells to eventually expand to a greater extent, perhaps by reducing competition for APCs or homeostatic
                     proliferation in the target tissue. These findings underscore the dynamic nature of autoimmune responses after altering the
                     T-cell repertoire to a single self-antigen and the potential for unexpected consequences.
                  </p>
                  
                  <p id="p-23">It is unknown whether an initiating antigen exits in human type 1 diabetes. Central and peripheral tolerance induction mechanisms
                     should only leave T-cells that interact with β-CAAs at subactivation thresholds. Theoretically, when a perturbation in antigen
                     presentation arises from islet remodeling, metabolic demands, or local inflammation, T-cells (reactive to multiple β-CAAs)
                     that were previously interacting with cognate β-CAAs at just below activation thresholds should receive sufficient stimulation
                     to activate and expand, causing multiple initial beaks in self-tolerance. In this case, enforcing passive tolerance to a single
                     β-CAA in preautoimmune humans may have little benefit, unless there are key driver T-cell autoreactivities.
                  </p>
                  
                  <p id="p-24">The administration of self-antigens intravenously in the absence of sufficient costimulatory signals is a classic modality
                     to induce passive tolerance. However, continued antigen treatments may be necessary to enforce passive tolerance because new
                     naive T-cells will emerge from the thymus. Moreover, the induction of passive tolerance to single autoantigen after the onset
                     of autoimmunity is unlikely to be effective because T-cell reactivities to other β-CAAs can drive disease progression. Accordingly,
                     after the onset of autoimmunity, the induction of long-lived regulatory responses is, theoretically, a better therapeutic
                     strategy.
                  </p>
                  
                  
                  
                  <h3>Prevention trials of antigen-based therapies for those at risk for type 1 diabetes.</h3>
                  
                  <p id="p-25">The Diabetes Prevention Trial (DPT)-1 tested whether daily subcutaneous insulin injections and annual intravenous insulin
                     infusions could prevent disease in individuals at high risk for developing type 1 diabetes. This treatment was geared to induce
                     β-cell rest, but immunological mechanisms might also be evoked because insulin treatment can boost insulin autoantibodies
                     and induce Th2 responses (<a id="xref-ref-39-2" class="xref-bibr" href="#ref-39">39</a>). The DPT-1 found no effect on type 1 diabetes incidence (<a id="xref-ref-47-1" class="xref-bibr" href="#ref-47">47</a>). Because the treatment did not alter the subject's insulin autoantibody (IAA) levels, its immunological impact has been
                     questioned. Another arm of the DPT-1 found that oral insulin treatment had no overall effect (<a id="xref-ref-48-1" class="xref-bibr" href="#ref-48">48</a>) but did delay type 1 diabetes onset in a subpopulation with high IAA (<a id="xref-ref-49-1" class="xref-bibr" href="#ref-49">49</a>). Understanding the beneficial effect of treatment in this subpopulation may help in designing more efficacious ABTs. Reasons
                     for the overall lack of efficacy could include suboptimal dose, degradation of the immunogen, weak immunogenicity via this
                     route, and simultaneous induction of regulatory and pathogenic responses.
                  </p>
                  
                  <p id="p-26">The Type 1 Diabetes Prediction and Prevention Study concluded that daily intranasal insulin treatment could not prevent or
                     delay diabetes, even when treatment began soon after autoantibodies arose (<a id="xref-ref-50-1" class="xref-bibr" href="#ref-50">50</a>). There were no changes in β-cell–reactive antibodies associated with treatment. In contrast, the Intranasal Insulin Trial
                     showed that intranasal insulin administration to individuals at high risk for developing type 1 diabetes increased antibodies
                     and decreased T-cell responses to insulin, and a subsequent clinical trial is in progress (<a id="xref-ref-40-2" class="xref-bibr" href="#ref-40">40</a>). Together, these initial prevention studies have been reassuring in terms of safety, but have raised questions about immunological
                     impact, optimal mode of antigen delivery, and antigen dose.
                  </p>
                  
                  
                  
                  <h3>Intervention trials of ABTs in recent-onset type 1 diabetic patients.</h3>
                  
                  <p id="p-27">Disease prevention is preferable to intervention after disease onset, but requires screening individuals for type 1 diabetes
                     risk markers and runs the risk of exacerbating the disease process. Intervention trials are more affordable because potential
                     subjects are readily identified and efficacy can be evaluated within a shorter time frame. Preserving residual β-cell function
                     after type 1 diabetes onset may prevent or delay long-term complications.
                  </p>
                  
                  
                  
                  <h3>Insulin-based intervention trials.</h3>
                  
                  <p id="p-28">There have been four clinical trials of oral insulin and one trial of an altered insulin B-chain peptide (NBI-6024, subcutaneous)
                     in newly diabetic individuals (<a id="xref-ref-41-2" class="xref-bibr" href="#ref-41">41</a>,<a id="xref-ref-51-1" class="xref-bibr" href="#ref-51">51</a>–<a id="xref-ref-53-1" class="xref-bibr" href="#ref-53">53</a>). Most have observed no protective effect on residual β-cell function and no study-related change in autoantibodies to β-CAAs
                     (<a id="xref-ref-51-2" class="xref-bibr" href="#ref-51">51</a>–<a id="xref-ref-53-2" class="xref-bibr" href="#ref-53">53</a>). One study observed a slower decline in plasma C-peptide levels in a subpopulation of patients (<a id="xref-ref-41-3" class="xref-bibr" href="#ref-41">41</a>). However, two studies found tendencies for basal C-peptide to decline faster in an oral insulin–treated subgroup (<a id="xref-ref-41-4" class="xref-bibr" href="#ref-41">41</a>,<a id="xref-ref-52-3" class="xref-bibr" href="#ref-52">52</a>), raising concern that treatment could in some cases accelerate the disease process. In other studies, intradermal treatment
                     with a low dose (30 μg), but not a high dose (300 μg), of a soluble DR4-restricted proinsulin peptide induced transient IL-10–secreting
                     T-cell responses in patients with long-standing type 1 diabetes (<a id="xref-ref-54-1" class="xref-bibr" href="#ref-54">54</a>).
                  </p>
                  
                  
                  
                  <h3>Intervention trials using HSPp277.</h3>
                  
                  <p id="p-29">There have been several small clinical trials of vaccination with an altered HSPp277 peptide in an adjuvant (Diapep), which
                     induces IL-10– (predominantly), IL-4–, and IL-13 antigen–specific responses (rev. in [<a id="xref-ref-55-1" class="xref-bibr" href="#ref-55">55</a>]). Most of these studies have reported a beneficial effect. Individuals with higher IL-10 before treatment responded better
                     to treatment. Paralleling this finding, another study found that new-onset type 1 diabetic patients with more IL-10 production
                     are more likely to experience a honeymoon phase (<a id="xref-ref-56-1" class="xref-bibr" href="#ref-56">56</a>). These observations suggest that the individual's predispositions to develop regulatory responses and/or preexisting immune
                     responses may influence ABT-induced responses.
                  </p>
                  
                  
                  
                  <h3>GAD/alum vaccine in LADA and new-onset type 1 diabetes.</h3>
                  
                  <p id="p-30">Clinical trials of GAD/alum vaccination were first conducted in individuals with LADA, a slowly progressing form of type 1
                     diabetes (<a id="xref-table-wrap-1-3" class="xref-table" href="#T1">Table 1</a>) (<a id="xref-ref-42-2" class="xref-bibr" href="#ref-42">42</a>). Subjects received placebo or GAD/alum (4, 20, 100, or 500 μg) subcutaneously, twice. Only the 500-μg dose boosted GAD autoantibody
                     levels. After 6 months, the CD4<sup>+</sup>CD25<sup>+</sup>/CD4<sup>+</sup>CD25<sup>−</sup> cell ratio, as well as serum C-peptide levels, increased from baseline only in the 20-μg–dose group. Evidently, ABT can have
                     a beneficial immunomodulatory effect without changing humoral responses to the administered antigen, at least in LADA patients.
                     A 5-year follow-up reported no significant study-related adverse effects and that C-peptide levels were significantly higher
                     only in the 20-μg–dose group (<a id="xref-ref-57-1" class="xref-bibr" href="#ref-57">57</a>). If confirmed, this treatment may provide a safe long-term therapy to preserve β-cell function in LADA patients.
                  </p>
                  
                  <p id="p-31">The mechanisms underlying the apparent effectiveness of the 20-μg dose, but not other dosages, are not yet evident. Multiple
                     low doses of antigen often induce tolerance by priming regulatory responses. High antigen/adjuvant dosages often induce tolerance
                     by exhausting antigen-specific T-cells but can promote humoral responses because some antigen escapes from the adjuvant and
                     can directly activate memory B-cells, which may explain why the high GAD/alum dose was ineffective but boosted GAD autoantibodies.
                     Alternatively, each GAD/alum dose may have evoked a different mixture of immune responses (i.e., regulatory responses, boosting
                     of pathogenic responses, exhaustion, anergy, and deletion). The 20-μg dose may have induced the most favorable ratio of beneficial/pathogenic
                     responses to promote functional tolerance. The notion that treatment induced a mixture of immune responses is supported by
                     observations that compared with PBMCs from placebo-treated controls, PBMCs from GAD/alum-treated type 1 diabetic subjects
                     secreted higher levels of a diverse array of cytokines in response to GAD (see below).
                  </p>
                  
                  <p id="p-32">The beneficial effect of the 20-μg GAD/alum dose was further supported by a subsequent larger clinical trial with newly diabetic
                     children (<a id="xref-ref-32-3" class="xref-bibr" href="#ref-32">32</a>). This study found that GAD/alum (20 μg) vaccination preserved β-cell function in patients treated within 6 months of type
                     1 diabetes onset but not in those treated &gt;6 months after type 1 diabetes onset. The effectiveness of treatment in more recently
                     diagnosed patients is likely to reflect greater remaining β-cell mass. This parallels findings with anti-CD3 treatment in
                     which the treatment was most effective in those with the highest residual β-cell function at the time of treatment (<a id="xref-ref-31-2" class="xref-bibr" href="#ref-31">31</a>). The treatment induced higher levels of IL-5, IL-10, and IL-13 GAD-specific responses accompanied by higher frequency of
                     Foxp3<sup>+</sup> and TGFβ-secreting T-cells, even after 15 months (<a id="xref-ref-32-4" class="xref-bibr" href="#ref-32">32</a>). Interestingly, treatment also promoted higher levels of some proinflammatory cytokine responses to GAD. It is possible
                     that these proinflammatory factors were counteracted by the enhanced regulatory responses or that these factors participated
                     in regulatory circuits. In contrast to the LADA study, GAD/alum treatment greatly boosted GAD autoantibodies in new-onset
                     type 1 diabetic patients, indicating a difference in immune responses to GAD/alum vaccination depending on whether the individual
                     had a slow or more aggressive disease process. Further analysis revealed that the best responders to GAD/alum were individuals
                     with higher initial levels of GAD autoantibody (<a id="xref-ref-58-1" class="xref-bibr" href="#ref-58">58</a>), an observation reminiscent of oral insulin's beneficial effects in individuals with high IAA at entry into the DPT-1 (<a id="xref-ref-49-2" class="xref-bibr" href="#ref-49">49</a>).
                  </p>
                  
                  <p id="p-33">In this study, the major factor affecting a subject's responsiveness to therapy was time to treatment, suggesting that residual
                     β-cell mass at the time of treatment is a major factor influencing GAD/alum effectiveness. In this regard, it is notable that
                     LADA patients, who are likely to have more β-cell mass than new-onset type 1 diabetic patients (i.e., they are not yet insulin
                     dependent), actually increased their C-peptide secretion over baseline 1 year after 20-μg GAD/alum treatment (<a id="xref-ref-42-3" class="xref-bibr" href="#ref-42">42</a>). Importantly, although insulin secretion gradually decreased in GAD/alum-treated new-onset type 1 diabetic patients, the
                     rate of decline was similar to that reported after anti-CD3 treatment (<a id="xref-ref-31-3" class="xref-bibr" href="#ref-31">31</a>,<a id="xref-ref-32-5" class="xref-bibr" href="#ref-32">32</a>,<a id="xref-ref-59-1" class="xref-bibr" href="#ref-59">59</a>). However, GAD/alum therapy did not have significant adverse side effects. This, together with the relative stability of
                     GAD/alum preparations, may make this treatment well suited for use in developing countries.
                  </p>
                  
                  
                  
                  <h3>The safety of ABTs.</h3>
                  
                  <p id="p-34">There is abundant evidence from animal models that ABTs can have potentially deleterious effects. For example, when neonatal
                     NOD mice are vaccinated with any β-CAA in IFA, they develop precocious Th2 (predominantly) and some Th1 responses to the administered
                     β-CAA by 4 weeks of age (<a id="xref-ref-21-2" class="xref-bibr" href="#ref-21">21</a>). Thus, despite treating NOD mice well before the onset of insulitis and using a Th2-promoting adjuvant, ABT promoted some
                     Th1 responses to the injected β-CAA. Apparently, partially or fully activated Th1 cells reactive to many different β-CAAs
                     are already present in NOD mice well before the development of insulitis, which can rapidly expand to detectable levels in
                     the context of increased autoantigen stimulation (<a id="xref-ref-21-3" class="xref-bibr" href="#ref-21">21</a>). Additionally, oral insulin exacerbated disease in BB rats, insulin B(9–23)/IFA boosted cognate Th1 responses in older NOD
                     mice, mucosal autoantigen delivery can prime pathogenic CD8<sup>+</sup> T-cell responses (<a id="xref-ref-40-3" class="xref-bibr" href="#ref-40">40</a>), repeated administration of β-CAA peptides can induce anaphylaxis, Th2 cells can induce disease in immunodeficient mice,
                     and induced autoimmunity to HSPs can lead to destruction of retinal cells in rats. Finally, GAD autoimmunity is often found
                     in individuals with a rare neurological disorder called stiff-person's syndrome and sometimes in other rare neurodegenerative
                     diseases, raising concerns that ABTs that boost GAD autoimmunity could have deleterious neurological consequences.
                  </p>
                  
                  <p id="p-35">In type 1 diabetes clinical trials thus far, there is some indication that oral insulin can accelerate the reduction in C-peptide
                     levels in some new-onset type 1 diabetic patient subgroups (<a id="xref-ref-41-5" class="xref-bibr" href="#ref-41">41</a>,<a id="xref-ref-52-4" class="xref-bibr" href="#ref-52">52</a>) and that depending on the dose, oral insulin may be beneficial or deleterious (<a id="xref-ref-41-6" class="xref-bibr" href="#ref-41">41</a>). Although the lack of ABT beneficial effects in most type 1 diabetes clinical trials has been ascribed to an insufficient
                     immunological impact, it could also reflect ABTs inducing both beneficial and pathogenic responses that counteracted one another.
                     Due to the potential to accelerate β-cell damage, ABT trials should first be tested for their ability to preserve residual
                     β-cell mass in new-onset type 1 diabetic patients and assessed for their long-term safety before extending the treatment to
                     the pre-diabetic population.
                  </p>
                  
                  
                  
                  <h3>Markers of therapeutic efficacy.</h3>
                  
                  <p id="p-36">Studies of ABTs in NOD mice, as well as studies of cancer vaccines in humans, have found that the magnitude of the antigen-induced
                     immune response and the extent of determinant spreading of T-cell responses to other target tissue antigens are associated
                     with better clinical outcomes (<a id="xref-ref-28-13" class="xref-bibr" href="#ref-28">28</a>,<a id="xref-ref-60-1" class="xref-bibr" href="#ref-60">60</a>). Currently, there are no surrogate immunological markers of ABT efficacy in humans. These are urgently needed to quickly
                     assess candidate treatments rather than relying on the long-term clinical outcome. Although induction antigen–specific IgG<sub>1</sub> is associated with the induction of regulatory Th2 responses in mice (e.g., [<a id="xref-ref-23-4" class="xref-bibr" href="#ref-23">23</a>]), such autoantibody isotype associations are not clear in humans. Moreover, humoral responses may not be associated with
                     therapeutic efficacy, as observed in GAD/alum-treated LADA patients (<a id="xref-ref-42-4" class="xref-bibr" href="#ref-42">42</a>).
                  </p>
                  
                  <p id="p-37">Determining the magnitude and functional phenotype of T-cell responses in humans currently requires multiple labor-intensive
                     assays. Autoantigen-specific T-cells are present in blood at very low frequency, such that the development of assays that
                     can reproducibly measure T-cell responses to multiple β-CAAs simultaneously at the single T-cell level will be valuable. These
                     assays, together with the measurement of different subclasses of β-CAA–specific antibodies, may allow assessments of the efficacy
                     of ABTs in clinical trials. In addition, imaging technologies such as magnetic resonance imaging and positron emission tomography
                     have growing potential to noninvasively image islet inflammation and β-cell mass in humans, but are costly.
                  </p>
                  
                  
                  
                  <h3>Future prospects.</h3>
                  
                  <p id="p-38">ABTs have the advantage of being less immune invasive than immunosuppressive therapies and are relatively easy and inexpensive
                     to manufacture, administer, and store. ABT clinical trials are largely focused on intervention after type 1 diabetes onset
                     as a test platform. However, no ABT or systemic immune–modulating clinical intervention trial has achieved long-term euglycemia.
                     Accordingly, there is great interest in combination therapies that combine an immune modulator (antigen specific or systemic
                     immunosuppressant) with a factor that promotes β-cell regeneration. However, these treatments may need repeating, and permanent
                     remission may be hard to safely establish in the context of established autoimmunity and greatly diminished β-cell mass.
                  </p>
                  
                  <p id="p-39">Long-term goals should be fixed on preventing type 1 diabetes for multiple reasons: <em>1</em>) there are excellent genetic and autoantibody markers of susceptibility, and type 1 diabetes has a long prodomal phase; <em>2</em>) less invasive treatments may be efficacious at earlier stages of the disease process; <em>3</em>) prevention costs may be less than those of insulin therapy and treating long-term complications. An ABT that bolsters regulatory
                     responses to β-CAAs long-term in at-risk individuals appears to be the most promising and safe monotherapy. As preventive
                     therapies become available, it will be important to have inexpensive high-throughput screening methods to identify those at
                     risk for type 1 diabetes. Development of a blood spot collection card that can be mailed for autoantibody detection may enable
                     cost-effective surveillance and disease prevention.
                  </p>
                  
                  <p id="p-40">Areas of research that might yield insights for optimizing ABTs are presented in <a id="xref-table-wrap-2-1" class="xref-table" href="#T2">Table 2</a>. The success of some ABTs in phase II clinical trials engenders cautious optimism that new treatments will enable the prevention
                     of type 1 diabetes and help preserve β-cell function after type 1 diabetes onset.
                  </p>
                  
                  <div class="table pos-float" id="T2">
                     <div class="table-inline">
                        <div class="callout"><span>View this table:</span><ul class="callout-links">
                              <li><a href="1939/T2.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="1939/T2.expansion.html">In a new window</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="table-caption"><span class="table-label">TABLE 2</span> 
                        
                        <p id="p-41" class="first-child">Outstanding issues for ABTs for type 1 diabetes</p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  
               </div>
               <div class="section ack" id="ack-1">
                  <div class="section-nav"><a href="#sec-1" title="Previous Section" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="Footnotes" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Acknowledgments</h2>
                  
                  <p id="p-42">D.L.K. is on the scientific advisory board of Diamyd Medical and is a coinventor of GAD-related patents. No other potential
                     conflicts of interest relevant to this article were reported.
                  </p>
                  
                  <p id="p-43">We regret that reference limitations preclude our citing many reports that provided important contributions to the field.
                     We thank Angelica Olcott and other members of the Kaufman lab for their contributions as well as Michael Clare-Salzler for
                     his comments on the manuscript.
                  </p>
                  
               </div>
               <div class="section fn-group" id="fn-group-1">
                  <div class="section-nav"><a href="#ack-1" title="Acknowledgments" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="REFERENCES" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Footnotes</h2>
                  <ul>
                     <li class="history" id="history-1">
                        <ul class="history-list">
                           <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                               hwp:start="2009-03-24"><span class="received-label">Received </span>March         24, 2009.
                           </li>
                           <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                               hwp:start="2009-05-21"><span class="accepted-label">Accepted </span>May         21, 2009.
                           </li>
                        </ul>
                     </li>
                     <li class="license" id="license-1">
                        
                        <p id="p-1">Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work
                           is not altered. See <a href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</a> for details.
                        </p>
                     </li>
                     <li class="copyright-statement" id="copyright-statement-1">© 2009 by the American Diabetes Association.</li>
                  </ul>
               </div>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#fn-group-1" title="Footnotes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>REFERENCES</h2>
                  <ol class="cit-list">
                     <li><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1 in text"
                           id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.1">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roep</span>  <span class="cit-name-given-names">BO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Atkinson</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">von Herrath</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Nat Rev Immunol</abbr>
                                 <span class="cit-pub-date">2004</span>;
                                 <span class="cit-vol">4</span>:
                                 <span class="cit-fpage">989</span>–
                                 <span class="cit-lpage">997</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/nri1502&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15573133&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2 in text"
                           id="ref-2">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.2">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Akirav</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kushner</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Herold</span>  <span class="cit-name-given-names">KC</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">β-Cell mass and type 1 diabetes: going, going, gone?</span>
                                 <abbr class="cit-jnl-abbrev">Diabetes</abbr>
                                 <span class="cit-pub-date">2008</span>;
                                 <span class="cit-vol">57</span>:
                                 <span class="cit-fpage">2883</span>–
                                 <span class="cit-lpage">2888</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=diabetes&amp;resid=57/11/2883"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3 in text"
                           id="ref-3">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.3">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Staeva-Vieira</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Peakman</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">von Herrath</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Translational mini-review series on type 1 diabetes: immune-based therapeutic approaches for type 1 diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Clin Exp Immunol</abbr>
                                 <span class="cit-pub-date">2007</span>;
                                 <span class="cit-vol">148</span>:
                                 <span class="cit-fpage">17</span>–
                                 <span class="cit-lpage">31</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=17349010&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4 in text"
                           id="ref-4">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.4">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clare-Salzler</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Forsthuber</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ting</span>  <span class="cit-name-given-names">GS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Robinson</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Atkinson</span>  <span class="cit-name-given-names">MA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sercarz</span>  <span class="cit-name-given-names">EE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tobin</span>  <span class="cit-name-given-names">AJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lehmann</span>  <span class="cit-name-given-names">PV</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Nature</abbr>
                                 <span class="cit-pub-date">1993</span>;
                                 <span class="cit-vol">366</span>:
                                 <span class="cit-fpage">69</span>–
                                 <span class="cit-lpage">72</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/366069a0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7694152&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5 in text"
                           id="ref-5">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tisch</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yang</span>  <span class="cit-name-given-names">XD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Singer</span>  <span class="cit-name-given-names">SM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Liblau</span>  <span class="cit-name-given-names">RS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fugger</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">McDevitt</span>  <span class="cit-name-given-names">HO</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice</span>.
                                 <abbr class="cit-jnl-abbrev">Nature</abbr>
                                 <span class="cit-pub-date">1993</span>;
                                 <span class="cit-vol">366</span>:
                                 <span class="cit-fpage">72</span>–
                                 <span class="cit-lpage">75</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/366072a0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8232539&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6 in text"
                           id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.6">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Di Lorenzo</span>  <span class="cit-name-given-names">TP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Peakman</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roep</span>  <span class="cit-name-given-names">BO</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Translational mini-review series on type 1 diabetes: systematic analysis of T-cell epitopes in autoimmune diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Clin Exp Immunol</abbr>
                                 <span class="cit-pub-date">2007</span>;
                                 <span class="cit-vol">148</span>:
                                 <span class="cit-fpage">1</span>–
                                 <span class="cit-lpage">16</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=17349009&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7 in text"
                           id="ref-7">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.7">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Arif</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tree</span>  <span class="cit-name-given-names">TI</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Astill</span>  <span class="cit-name-given-names">TP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tremble</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bishop</span>  <span class="cit-name-given-names">AJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dayan</span>  <span class="cit-name-given-names">CM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roep</span>  <span class="cit-name-given-names">BO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Peakman</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Autoreactive T-cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Invest</abbr>
                                 <span class="cit-pub-date">2004</span>;
                                 <span class="cit-vol">113</span>:
                                 <span class="cit-fpage">451</span>–
                                 <span class="cit-lpage">463</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1172/JCI200419585&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=14755342&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8 in text"
                           id="ref-8">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ott</span>  <span class="cit-name-given-names">PA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Herzog</span>  <span class="cit-name-given-names">BA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Quast</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hofstetter</span>  <span class="cit-name-given-names">HH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Boehm</span>  <span class="cit-name-given-names">BO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tary-Lehmann</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Durinovic-Bello</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berner</span>  <span class="cit-name-given-names">BR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lehmann</span>  <span class="cit-name-given-names">PV</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Islet-cell antigen-reactive T-cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients
                                    and healthy controls</span>.
                                 <abbr class="cit-jnl-abbrev">Clin Immunol</abbr>
                                 <span class="cit-pub-date">2005</span>;
                                 <span class="cit-vol">115</span>:
                                 <span class="cit-fpage">102</span>–
                                 <span class="cit-lpage">114</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.clim.2004.12.005&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15870028&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9 in text"
                           id="ref-9">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.9">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ott</span>  <span class="cit-name-given-names">PA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dittrich</span>  <span class="cit-name-given-names">MT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Herzog</span>  <span class="cit-name-given-names">BA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Guerkov</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gottlieb</span>  <span class="cit-name-given-names">PA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Putnam</span>  <span class="cit-name-given-names">AL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Durinovic-Bello</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Boehm</span>  <span class="cit-name-given-names">BO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tary-Lehmann</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lehmann</span>  <span class="cit-name-given-names">PV</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">T-cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Immunol</abbr>
                                 <span class="cit-pub-date">2004</span>;
                                 <span class="cit-vol">24</span>:
                                 <span class="cit-fpage">327</span>–
                                 <span class="cit-lpage">339</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1023/B:JOCI.0000029120.77824.41&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15163889&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10 in text"
                           id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.10">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lehmann</span>  <span class="cit-name-given-names">PV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Targoni</span>  <span class="cit-name-given-names">OS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Forsthuber</span>  <span class="cit-name-given-names">TG</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Shifting T-cell activation thresholds in autoimmunity and determinant spreading</span>.
                                 <abbr class="cit-jnl-abbrev">Immunol Rev</abbr>
                                 <span class="cit-pub-date">1998</span>;
                                 <span class="cit-vol">164</span>:
                                 <span class="cit-fpage">53</span>–
                                 <span class="cit-lpage">61</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1111/j.1600-065X.1998.tb01207.x&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9795763&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11 in text"
                           id="ref-11">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.11">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gregori</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Adorini</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">The frequency of high avidity T-cells determines the hierarchy of determinant spreading</span>.
                                 <abbr class="cit-jnl-abbrev">J Immunol</abbr>
                                 <span class="cit-pub-date">2001</span>;
                                 <span class="cit-vol">166</span>:
                                 <span class="cit-fpage">7144</span>–
                                 <span class="cit-lpage">7150</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=166/12/7144"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12 in text"
                           id="ref-12">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.12">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Weiner</span>  <span class="cit-name-given-names">HL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Oral tolerance: immune mechanisms and treatment of autoimmune diseases</span>.
                                 <abbr class="cit-jnl-abbrev">Immunol Today</abbr>
                                 <span class="cit-pub-date">1997</span>;
                                 <span class="cit-vol">18</span>:
                                 <span class="cit-fpage">335</span>–
                                 <span class="cit-lpage">343</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0167-5699(97)01053-0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9238837&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13 in text"
                           id="ref-13">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.13">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lehmann</span>  <span class="cit-name-given-names">PV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Determinant spreading of T helper 2 (TH2) responses to pancreatic islet autoantigens</span>.
                                 <abbr class="cit-jnl-abbrev">J Exp Med</abbr>
                                 <span class="cit-pub-date">1997</span>;
                                 <span class="cit-vol">186</span>:
                                 <span class="cit-fpage">2039</span>–
                                 <span class="cit-lpage">2044</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jem&amp;resid=186/12/2039"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14 in text"
                           id="ref-14">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.14">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tisch</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wang</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Serreze</span>  <span class="cit-name-given-names">DV</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease
                                    is epitope dependent</span>.
                                 <abbr class="cit-jnl-abbrev">J Immunol</abbr>
                                 <span class="cit-pub-date">1999</span>;
                                 <span class="cit-vol">163</span>:
                                 <span class="cit-fpage">1178</span>–
                                 <span class="cit-lpage">1187</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=163/3/1178"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15 in text"
                           id="ref-15">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.15">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Olcott</span>  <span class="cit-name-given-names">AP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hanssen</span>  <span class="cit-name-given-names">LR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zekzer</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Middleton</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Infectious Th1 and Th2 immunity in diabetes prone mice</span>.
                                 <abbr class="cit-jnl-abbrev">Immunol Rev</abbr>
                                 <span class="cit-pub-date">1998</span>;
                                 <span class="cit-vol">164</span>:
                                 <span class="cit-fpage">119</span>–
                                 <span class="cit-lpage">127</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1111/j.1600-065X.1998.tb01214.x&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9795770&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16 in text"
                           id="ref-16">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.16">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yin</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Edling</span>  <span class="cit-name-given-names">AE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kawczak</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mathisen</span>  <span class="cit-name-given-names">PM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nanavati</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Johnson</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tuohy</span>  <span class="cit-name-given-names">VK</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T-cells during autoimmune demyelinating
                                    disease</span>.
                                 <abbr class="cit-jnl-abbrev">J Immunol</abbr>
                                 <span class="cit-pub-date">2001</span>;
                                 <span class="cit-vol">167</span>:
                                 <span class="cit-fpage">6105</span>–
                                 <span class="cit-lpage">6112</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=167/11/6105"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17 in text"
                           id="ref-17">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.17">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Waldmann</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Adams</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fairchild</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cobbold</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Infectious tolerance and the long-term acceptance of transplanted tissue</span>.
                                 <abbr class="cit-jnl-abbrev">Immunol Rev</abbr>
                                 <span class="cit-pub-date">2006</span>;
                                 <span class="cit-vol">212</span>:
                                 <span class="cit-fpage">301</span>–
                                 <span class="cit-lpage">313</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1111/j.0105-2896.2006.00406.x&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16903922&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18 in text"
                           id="ref-18">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.18">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tang</span>  <span class="cit-name-given-names">Q</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Adams</span>  <span class="cit-name-given-names">JY</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tooley</span>  <span class="cit-name-given-names">AJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bi</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fife</span>  <span class="cit-name-given-names">BT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Serra</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Santamaria</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Locksley</span>  <span class="cit-name-given-names">RM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Krummel</span>  <span class="cit-name-given-names">MF</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bluestone</span>  <span class="cit-name-given-names">JA</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Visualizing regulatory T-cell control of autoimmune responses in nonobese diabetic mice</span>.
                                 <abbr class="cit-jnl-abbrev">Nat Immunol</abbr>
                                 <span class="cit-pub-date">2006</span>;
                                 <span class="cit-vol">7</span>:
                                 <span class="cit-fpage">83</span>–
                                 <span class="cit-lpage">92</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/ni1289&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16311599&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19 in text"
                           id="ref-19">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.19">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Alpan</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bachelder</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Isil</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Arnheiter</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Matzinger</span>  <span class="cit-name-given-names">P</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">‘Educated’ dendritic cells act as messengers from memory to naive T helper cells</span>.
                                 <abbr class="cit-jnl-abbrev">Nat Immunol</abbr>
                                 <span class="cit-pub-date">2004</span>;
                                 <span class="cit-vol">5</span>:
                                 <span class="cit-fpage">615</span>–
                                 <span class="cit-lpage">622</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/ni1077&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15156140&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20 in text"
                           id="ref-20">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.20">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lu</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hanssen</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dang</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Memory and effector T-cells modulate subsequently primed immune responses to unrelated antigens</span>.
                                 <abbr class="cit-jnl-abbrev">Cell Immunol</abbr>
                                 <span class="cit-pub-date">2003</span>;
                                 <span class="cit-vol">224</span>:
                                 <span class="cit-fpage">74</span>–
                                 <span class="cit-lpage">85</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.cellimm.2003.08.007&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=14609573&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21 in text"
                           id="ref-21">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.21">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Olcott</span>  <span class="cit-name-given-names">AP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Antigen-based immunotherapy drives the precocious development of autoimmunity</span>.
                                 <abbr class="cit-jnl-abbrev">J Immunol</abbr>
                                 <span class="cit-pub-date">2002</span>;
                                 <span class="cit-vol">169</span>:
                                 <span class="cit-fpage">6564</span>–
                                 <span class="cit-lpage">6569</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=169/11/6564"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22 in text"
                           id="ref-22">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.22">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Attenuation of inducible Th2 immunity with autoimmune disease progression</span>.
                                 <abbr class="cit-jnl-abbrev">J Immunol</abbr>
                                 <span class="cit-pub-date">1998</span>;
                                 <span class="cit-vol">161</span>:
                                 <span class="cit-fpage">5399</span>–
                                 <span class="cit-lpage">5403</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=161/10/5399"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23 in text"
                           id="ref-23">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.23">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clare-Salzler</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Herschenfeld</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Middleton</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Newman</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mueller</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Arita</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Evans</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Atkinson</span>  <span class="cit-name-given-names">MA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mullen</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sarvetnick</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tobin</span>  <span class="cit-name-given-names">AJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lehmann</span>  <span class="cit-name-given-names">PV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice</span>.
                                 <abbr class="cit-jnl-abbrev">Nat Med</abbr>
                                 <span class="cit-pub-date">1996</span>;
                                 <span class="cit-vol">2</span>:
                                 <span class="cit-fpage">1348</span>–
                                 <span class="cit-lpage">1353</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/nm1296-1348&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8946834&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24 in text"
                           id="ref-24">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.24">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pugliese</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zeller</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fernandez</span>  <span class="cit-name-given-names">A</span>,  <span class="cit-name-suffix">Jr</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zalcberg</span>  <span class="cit-name-given-names">LJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bartlett</span>  <span class="cit-name-given-names">RJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ricordi</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pietropaolo</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Eisenbarth</span>  <span class="cit-name-given-names">GS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bennett</span>  <span class="cit-name-given-names">ST</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Patel</span>  <span class="cit-name-given-names">DD</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS
                                    VNTR-IDDM2 susceptibility locus for type 1 diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Nat Genet</abbr>
                                 <span class="cit-pub-date">1997</span>;
                                 <span class="cit-vol">15</span>:
                                 <span class="cit-fpage">293</span>–
                                 <span class="cit-lpage">297</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/ng0397-293&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9054945&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25 in text"
                           id="ref-25">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.25">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thebault-Baumont</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dubois-Laforgue</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Krief</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Briand</span>  <span class="cit-name-given-names">JP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Halbout</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vallon-Geoffroy</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Morin</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Laloux</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lehuen</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Carel</span>  <span class="cit-name-given-names">JC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jami</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Muller</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Boitard</span>  <span class="cit-name-given-names">C</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Invest</abbr>
                                 <span class="cit-pub-date">2003</span>;
                                 <span class="cit-vol">111</span>:
                                 <span class="cit-fpage">851</span>–
                                 <span class="cit-lpage">857</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1172/JCI200316584&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12639991&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26 in text"
                           id="ref-26">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.26">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kim</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Richter</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Aanstoot</span>  <span class="cit-name-given-names">HJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shi</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fu</span>  <span class="cit-name-given-names">Q</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rajotte</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Warnock</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Baekkeskov</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetes</abbr>
                                 <span class="cit-pub-date">1993</span>;
                                 <span class="cit-vol">42</span>:
                                 <span class="cit-fpage">1799</span>–
                                 <span class="cit-lpage">1808</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=diabetes&amp;resid=42/12/1799"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27 in text"
                           id="ref-27">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.27">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Severe</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gauvrit</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vu</span>  <span class="cit-name-given-names">AT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bach</span>  <span class="cit-name-given-names">JM</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">CD8+ T lymphocytes specific for glutamic acid decarboxylase 90–98 epitope mediate diabetes in NOD SCID mouse</span>.
                                 <abbr class="cit-jnl-abbrev">Mol Immunol</abbr>
                                 <span class="cit-pub-date">2007</span>;
                                 <span class="cit-vol">44</span>:
                                 <span class="cit-fpage">2950</span>–
                                 <span class="cit-lpage">2960</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.molimm.2007.01.008&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=17336387&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28 in text"
                           id="ref-28">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.28">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Olcott</span>  <span class="cit-name-given-names">AP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Walker</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dang</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Middleton</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Adorini</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Washburn</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune
                                    disease in diabetes-prone mice</span>.
                                 <abbr class="cit-jnl-abbrev">J Immunol</abbr>
                                 <span class="cit-pub-date">2005</span>;
                                 <span class="cit-vol">175</span>:
                                 <span class="cit-fpage">1991</span>–
                                 <span class="cit-lpage">1999</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=175/3/1991"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29 in text"
                           id="ref-29">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.29">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chatenoud</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thervet</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Primo</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bach</span>  <span class="cit-name-given-names">JF</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice</span>.
                                 <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci U S A</abbr>
                                 <span class="cit-pub-date">1994</span>;
                                 <span class="cit-vol">91</span>:
                                 <span class="cit-fpage">123</span>–
                                 <span class="cit-lpage">127</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=91/1/123"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30 in text"
                           id="ref-30">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.30">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">von Herrath</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Can we learn from viruses how to prevent type 1 diabetes?: the role of viral infections in the pathogenesis of type 1 diabetes
                                    and the development of novel combination therapies</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetes</abbr>
                                 <span class="cit-pub-date">2009</span>;
                                 <span class="cit-vol">58</span>:
                                 <span class="cit-fpage">2</span>–
                                 <span class="cit-lpage">11</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=diabetes&amp;resid=58/1/2"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31 in text"
                           id="ref-31">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.31">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Keymeulen</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vandemeulebroucke</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ziegler</span>  <span class="cit-name-given-names">AG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mathieu</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hale</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gorus</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Goldman</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Walter</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Candon</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schandene</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Crenier</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">De Block</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Seigneurin</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">De Pauw</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pierard</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Weets</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rebello</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bird</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berrie</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Frewin</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Waldmann</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bach</span>  <span class="cit-name-given-names">JF</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pipeleers</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chatenoud</span>  <span class="cit-name-given-names">L</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>
                                 <span class="cit-pub-date">2005</span>;
                                 <span class="cit-vol">352</span>:
                                 <span class="cit-fpage">2598</span>–
                                 <span class="cit-lpage">2608</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa043980&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15972866&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32 in text"
                           id="ref-32">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.32">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ludvigsson</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Faresjo</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hjorth</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Axelsson</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cheramy</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pihl</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vaarala</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Forsander</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ivarsson</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Johansson</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lindh</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nilsson</span>  <span class="cit-name-given-names">NO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Aman</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ortqvist</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zerhouni</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Casas</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">GAD treatment and insulin secretion in recent-onset type 1 diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>
                                 <span class="cit-pub-date">2008</span>;
                                 <span class="cit-vol">359</span>:
                                 <span class="cit-fpage">1909</span>–
                                 <span class="cit-lpage">1920</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa0804328&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=18843118&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33 in text"
                           id="ref-33">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.33">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pop</span>  <span class="cit-name-given-names">SM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wong</span>  <span class="cit-name-given-names">CP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">He</span>  <span class="cit-name-given-names">Q</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wang</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wallet</span>  <span class="cit-name-given-names">MA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Goudy</span>  <span class="cit-name-given-names">KS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tisch</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">The type and frequency of immunoregulatory CD4<sup>+</sup> T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetes</abbr>
                                 <span class="cit-pub-date">2007</span>;
                                 <span class="cit-vol">56</span>:
                                 <span class="cit-fpage">1395</span>–
                                 <span class="cit-lpage">1402</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2337/db06-0543&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=17317763&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference 34 in text"
                           id="ref-34">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.34">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sercarz</span>  <span class="cit-name-given-names">EE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lehmann</span>  <span class="cit-name-given-names">PV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ametani</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Benichou</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Miller</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moudgil</span>  <span class="cit-name-given-names">K</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Dominance and crypticity of T-cell antigenic determinants</span>.
                                 <abbr class="cit-jnl-abbrev">Annu Rev Immunol</abbr>
                                 <span class="cit-pub-date">1993</span>;
                                 <span class="cit-vol">11</span>:
                                 <span class="cit-fpage">729</span>–
                                 <span class="cit-lpage">766</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1146/annurev.iy.11.040193.003501&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7682817&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference 35 in text"
                           id="ref-35">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.35">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moudgil</span>  <span class="cit-name-given-names">KD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sercarz</span>  <span class="cit-name-given-names">EE</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">The self-directed T-cell repertoire: its creation and activation</span>.
                                 <abbr class="cit-jnl-abbrev">Rev Immunogenet</abbr>
                                 <span class="cit-pub-date">2000</span>;
                                 <span class="cit-vol">2</span>:
                                 <span class="cit-fpage">26</span>–
                                 <span class="cit-lpage">37</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=11324691&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference 36 in text"
                           id="ref-36">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.36">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bolonaki</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kotsakis</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Papadimitraki</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Aggouraki</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Konsolakis</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vagia</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Christophylakis</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nikoloudi</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Magganas</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Galanis</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cordopatis</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kosmatopoulos</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Georgoulias</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mavroudis</span>  <span class="cit-name-given-names">D</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase
                                    peptide</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>
                                 <span class="cit-pub-date">2007</span>;
                                 <span class="cit-vol">25</span>:
                                 <span class="cit-fpage">2727</span>–
                                 <span class="cit-lpage">2734</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=25/19/2727"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37 in text"
                           id="ref-37">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.37">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shirakawa</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Enomoto</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shimazu</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hopkin</span>  <span class="cit-name-given-names">JM</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">The inverse association between tuberculin responses and atopic disorder</span>.
                                 <abbr class="cit-jnl-abbrev">Science</abbr>
                                 <span class="cit-pub-date">1997</span>;
                                 <span class="cit-vol">275</span>:
                                 <span class="cit-fpage">77</span>–
                                 <span class="cit-lpage">79</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=275/5296/77"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38 in text"
                           id="ref-38">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.38">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Guéry</span>  <span class="cit-name-given-names">JC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Galbiati</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Smiroldo</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Adorini</span>  <span class="cit-name-given-names">L</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal
                                    and beta(2)-microglobulin-deficient BALB/c mice</span>.
                                 <abbr class="cit-jnl-abbrev">J Exp Med</abbr>
                                 <span class="cit-pub-date">1996</span>;
                                 <span class="cit-vol">183</span>:
                                 <span class="cit-fpage">485</span>–
                                 <span class="cit-lpage">497</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jem&amp;resid=183/2/485"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference 39 in text"
                           id="ref-39">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.39">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tian</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kaufman</span>  <span class="cit-name-given-names">DL</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diebetic mice</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetologia</abbr>
                                 <span class="cit-pub-date">1998</span>;
                                 <span class="cit-vol">41</span>:
                                 <span class="cit-fpage">237</span>–
                                 <span class="cit-lpage">240</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s001250050896&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9498660&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference 40 in text"
                           id="ref-40">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.40">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Harrison</span>  <span class="cit-name-given-names">LC</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Vaccination against self to prevent autoimmune disease: the type 1 diabetes model</span>.
                                 <abbr class="cit-jnl-abbrev">Immunol Cell Biol</abbr>
                                 <span class="cit-pub-date">2008</span>;
                                 <span class="cit-vol">86</span>:
                                 <span class="cit-fpage">139</span>–
                                 <span class="cit-lpage">145</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=18180798&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-41-1" title="View reference 41 in text"
                           id="ref-41">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.41">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ergun-Longmire</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Marker</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zeidler</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rapaport</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Raskin</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bode</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schatz</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vargas</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rogers</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schwartz</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Malone</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Krischer</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Maclaren</span>  <span class="cit-name-given-names">NK</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Ann N Y Acad Sci</abbr>
                                 <span class="cit-pub-date">2004</span>;
                                 <span class="cit-vol">1029</span>:
                                 <span class="cit-fpage">260</span>–
                                 <span class="cit-lpage">277</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1196/annals.1309.057&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15681764&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-42-1" title="View reference 42 in text"
                           id="ref-42">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.42">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Agardh</span>  <span class="cit-name-given-names">CD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cilio</span>  <span class="cit-name-given-names">CM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lethagen</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lynch</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Leslie</span>  <span class="cit-name-given-names">RD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Palmer</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Harris</span>  <span class="cit-name-given-names">RA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Robertson</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lernmark</span>  <span class="cit-name-given-names">A</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">J Diabetes Complications</abbr>
                                 <span class="cit-pub-date">2005</span>;
                                 <span class="cit-vol">19</span>:
                                 <span class="cit-fpage">238</span>–
                                 <span class="cit-lpage">246</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.jdiacomp.2004.12.003&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15993359&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-43-1" title="View reference 43 in text"
                           id="ref-43">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.43">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">French</span>  <span class="cit-name-given-names">MB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Allison</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cram</span>  <span class="cit-name-given-names">DS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thomas</span>  <span class="cit-name-given-names">HE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dempsey-Collier</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Silva</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Georgiou</span>  <span class="cit-name-given-names">HM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kay</span>  <span class="cit-name-given-names">TW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Harrison</span>  <span class="cit-name-given-names">LC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lew</span>  <span class="cit-name-given-names">AM</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetes</abbr>
                                 <span class="cit-pub-date">1997</span>;
                                 <span class="cit-vol">46</span>:
                                 <span class="cit-fpage">34</span>–
                                 <span class="cit-lpage">39</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=diabetes&amp;resid=46/1/34"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-44-1" title="View reference 44 in text"
                           id="ref-44">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.44">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nakayama</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Abiru</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moriyama</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Babaya</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Liu</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Miao</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wegmann</span>  <span class="cit-name-given-names">DR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hutton</span>  <span class="cit-name-given-names">JC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Elliott</span>  <span class="cit-name-given-names">JF</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Eisenbarth</span>  <span class="cit-name-given-names">GS</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice</span>.
                                 <abbr class="cit-jnl-abbrev">Nature</abbr>
                                 <span class="cit-pub-date">2005</span>;
                                 <span class="cit-vol">435</span>:
                                 <span class="cit-fpage">220</span>–
                                 <span class="cit-lpage">223</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/nature03523&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15889095&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-45-1" title="View reference 45 in text"
                           id="ref-45">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.45">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yoon</span>  <span class="cit-name-given-names">JW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yoon</span>  <span class="cit-name-given-names">CS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lim</span>  <span class="cit-name-given-names">HW</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Huang</span>  <span class="cit-name-given-names">QQ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kang</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pyun</span>  <span class="cit-name-given-names">KH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hirasawa</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sherwin</span>  <span class="cit-name-given-names">RS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jun</span>  <span class="cit-name-given-names">HS</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells</span>.
                                 <abbr class="cit-jnl-abbrev">Science</abbr>
                                 <span class="cit-pub-date">1999</span>;
                                 <span class="cit-vol">284</span>:
                                 <span class="cit-fpage">1183</span>–
                                 <span class="cit-lpage">1187</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=284/5417/1183"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-46-1" title="View reference 46 in text"
                           id="ref-46">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.46">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jaeckel</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Klein</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Martin-Orozco</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">von Boehmer</span>  <span class="cit-name-given-names">H</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase</span>.
                                 <abbr class="cit-jnl-abbrev">J Exp Med</abbr>
                                 <span class="cit-pub-date">2003</span>;
                                 <span class="cit-vol">197</span>:
                                 <span class="cit-fpage">1635</span>–
                                 <span class="cit-lpage">1644</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jem&amp;resid=197/12/1635"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-47-1" title="View reference 47 in text"
                           id="ref-47">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.47">
                           <div class="cit-metadata"><cite>
                                 <span class="cit-article-title">Effects of insulin in relatives of patients with type 1 diabetes mellitus</span>.
                                 <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>
                                 <span class="cit-pub-date">2002</span>;
                                 <span class="cit-vol">346</span>:
                                 <span class="cit-fpage">1685</span>–
                                 <span class="cit-lpage">1691</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa012350&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12037147&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-48-1" title="View reference 48 in text"
                           id="ref-48">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.48">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Barker</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">McFann</span>  <span class="cit-name-given-names">KK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Orban</span>  <span class="cit-name-given-names">T</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetologia</abbr>
                                 <span class="cit-pub-date">2007</span>;
                                 <span class="cit-vol">50</span>:
                                 <span class="cit-fpage">1603</span>–
                                 <span class="cit-lpage">1606</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s00125-007-0694-0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=17583798&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-49-1" title="View reference 49 in text"
                           id="ref-49">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.49">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Skyler</span>  <span class="cit-name-given-names">JS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Krischer</span>  <span class="cit-name-given-names">JP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wolfsdorf</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cowie</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Palmer</span>  <span class="cit-name-given-names">JP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Greenbaum</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cuthbertson</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rafkin-Mervis</span>  <span class="cit-name-given-names">LE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chase</span>  <span class="cit-name-given-names">HP</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Leschek</span>  <span class="cit-name-given-names">E</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial–Type 1</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetes Care</abbr>
                                 <span class="cit-pub-date">2005</span>;
                                 <span class="cit-vol">28</span>:
                                 <span class="cit-fpage">1068</span>–
                                 <span class="cit-lpage">1076</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=diacare&amp;resid=28/5/1068"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-50-1" title="View reference 50 in text"
                           id="ref-50">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.50">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nanto-Salonen</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kupila</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Simell</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Siljander</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Salonsaari</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hekkala</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Korhonen</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Erkkola</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sipila</span>  <span class="cit-name-given-names">JI</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Haavisto</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Siltala</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tuominen</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hakalax</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hyoty</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ilonen</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Veijola</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Simell</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Knip</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Simell</span>  <span class="cit-name-given-names">O</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease:
                                    a double-blind, randomised controlled trial</span>.
                                 <abbr class="cit-jnl-abbrev">Lancet</abbr>
                                 <span class="cit-pub-date">2008</span>;
                                 <span class="cit-vol">372</span>:
                                 <span class="cit-fpage">1746</span>–
                                 <span class="cit-lpage">1755</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(08)61309-4&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=18814906&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-51-1" title="View reference 51 in text"
                           id="ref-51">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.51">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chaillous</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lefevre</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thivolet</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Boitard</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lahlou</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Atlan-Gepner</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bouhanick</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mogenet</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nicolino</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Carel</span>  <span class="cit-name-given-names">JC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lecomte</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Marechaud</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bougneres</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Charbonnel</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sai</span>  <span class="cit-name-given-names">P</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled
                                    trial. Diabete Insuline Orale group</span>.
                                 <abbr class="cit-jnl-abbrev">Lancet</abbr>
                                 <span class="cit-pub-date">2000</span>;
                                 <span class="cit-vol">356</span>:
                                 <span class="cit-fpage">545</span>–
                                 <span class="cit-lpage">549</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(00)02579-4&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10950231&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-52-1" title="View reference 52 in text"
                           id="ref-52">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.52">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pozzilli</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pitocco</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Visalli</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cavallo</span>  <span class="cit-name-given-names">MG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buzzetti</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Crino</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Spera</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Suraci</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Multari</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cervoni</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Manca Bitti</span>  <span class="cit-name-given-names">ML</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Matteoli</span>  <span class="cit-name-given-names">MC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Marietti</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ferrazzoli</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cassone Faldetta</span>  <span class="cit-name-given-names">MR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Giordano</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sbriglia</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sarugeri</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ghirlanda</span>  <span class="cit-name-given-names">G</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.</span>
                                 <abbr class="cit-jnl-abbrev">Diabetologia</abbr>
                                 <span class="cit-pub-date">2000</span>;
                                 <span class="cit-vol">43</span>:
                                 <span class="cit-fpage">1000</span>–
                                 <span class="cit-lpage">1004</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s001250051482&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10990077&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-53-1" title="View reference 53 in text"
                           id="ref-53">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.53">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Monetini</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cavallo</span>  <span class="cit-name-given-names">MG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sarugeri</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sentinelli</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stefanini</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bosi</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thorpe</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pozzilli</span>  <span class="cit-name-given-names">P</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetologia</abbr>
                                 <span class="cit-pub-date">2004</span>;
                                 <span class="cit-vol">47</span>:
                                 <span class="cit-fpage">1795</span>–
                                 <span class="cit-lpage">1802</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s00125-004-1521-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15502927&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-54-1" title="View reference 54 in text"
                           id="ref-54">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.54">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thrower</span>  <span class="cit-name-given-names">SL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">James</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hall</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Green</span>  <span class="cit-name-given-names">KM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Arif</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Allen</span>  <span class="cit-name-given-names">JS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Van-Krinks</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lozanoska-Ochser</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Marquesini</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brown</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wong</span>  <span class="cit-name-given-names">FS</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dayan</span>  <span class="cit-name-given-names">CM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Peakman</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study</span>.
                                 <abbr class="cit-jnl-abbrev">Clin Exp Immunol</abbr>,
                                 <span class="cit-pub-date">2008</span></cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-55-1" title="View reference 55 in text"
                           id="ref-55">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.55">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Huurman</span>  <span class="cit-name-given-names">VA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van der Meide</span>  <span class="cit-name-given-names">PE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Duinkerken</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Willemen</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cohen</span>  <span class="cit-name-given-names">IR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Elias</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roep</span>  <span class="cit-name-given-names">BO</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Clin Exp Immunol</abbr>
                                 <span class="cit-pub-date">2008</span>;
                                 <span class="cit-vol">152</span>:
                                 <span class="cit-fpage">488</span>–
                                 <span class="cit-lpage">497</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=18422727&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-56-1" title="View reference 56 in text"
                           id="ref-56">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.56">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sanda</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roep</span>  <span class="cit-name-given-names">BO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">von Herrath</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type
                                    1 diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Clin Immunol</abbr>
                                 <span class="cit-pub-date">2008</span>;
                                 <span class="cit-vol">127</span>:
                                 <span class="cit-fpage">138</span>–
                                 <span class="cit-lpage">143</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.clim.2007.12.003&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=18304876&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-57-1" title="View reference 57 in text"
                           id="ref-57">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.57">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Agardh</span>  <span class="cit-name-given-names">CD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lynch</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Palmer</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Link</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lernmark</span>  <span class="cit-name-given-names">A</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetologia</abbr>
                                 <span class="cit-pub-date">2009</span>;
                                 <span class="cit-vol">52</span>:
                                 <span class="cit-fpage">1363</span>–
                                 <span class="cit-lpage">1368</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/s00125-009-1371-2&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19404608&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-58-1" title="View reference 58 in text"
                           id="ref-58">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.58">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cheramy</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ludvigsson</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Casas</span>  <span class="cit-name-given-names">R</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">GAD65 treatment induces high GADA levels in type 1 diabetic children-a relation to C-peptide response, but not adverse effects</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetologia</abbr>
                                 <span class="cit-pub-date">2008</span>;
                                 <span class="cit-vol">51</span>:
                                 <span class="cit-fpage">S231</span></cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-59-1" title="View reference 59 in text"
                           id="ref-59">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.59">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Herold</span>  <span class="cit-name-given-names">KC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gitelman</span>  <span class="cit-name-given-names">SE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Masharani</span>  <span class="cit-name-given-names">U</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hagopian</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bisikirska</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Donaldson</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rother</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Diamond</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Harlan</span>  <span class="cit-name-given-names">DM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bluestone</span>  <span class="cit-name-given-names">JA</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical
                                    parameters for at least 2 years after onset of type 1 diabetes</span>.
                                 <abbr class="cit-jnl-abbrev">Diabetes</abbr>
                                 <span class="cit-pub-date">2005</span>;
                                 <span class="cit-vol">54</span>:
                                 <span class="cit-fpage">1763</span>–
                                 <span class="cit-lpage">1769</span></cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=diabetes&amp;resid=54/6/1763"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-60-1" title="View reference 60 in text"
                           id="ref-60">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-58.9.1939.60">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ribas</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Timmerman</span>  <span class="cit-name-given-names">JM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Butterfield</span>  <span class="cit-name-given-names">LH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Economou</span>  <span class="cit-name-given-names">JS</span></span></li>
                              </ol><cite>
                                 :
                                 <span class="cit-article-title">Determinant spreading and tumor responses after peptide-based cancer immunotherapy</span>.
                                 <abbr class="cit-jnl-abbrev">Trends Immunol</abbr>
                                 <span class="cit-pub-date">2003</span>;
                                 <span class="cit-vol">24</span>:
                                 <span class="cit-fpage">58</span>–
                                 <span class="cit-lpage">61</span></cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S1471-4906(02)00029-7&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12547500&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                  </ol>
               </div>
            </div>
            <div class="social-bookmarking">
               
               <ul class="social-bookmark-links">
                  <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                             alt="Add to CiteULike"
                             title="CiteULike" /><span class="soc-bm-link-text">CiteULike</span></a></li>
                  <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                             alt="Add to Del.icio.us"
                             title="Del.icio.us" /><span class="soc-bm-link-text">Del.icio.us</span></a></li>
                  <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=DIGG"><img src="/shared/img/common/social-bookmarking/digg.gif" alt="Add to Digg"
                             title="Digg" /><span class="soc-bm-link-text">Digg</span></a></li>
                  <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=REDDIT"><img src="/shared/img/common/social-bookmarking/reddit.gif" alt="Add to Reddit"
                             title="Reddit" /><span class="soc-bm-link-text">Reddit</span></a></li>
                  <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=TECHNORATI"><img src="/shared/img/common/social-bookmarking/technorati.gif"
                             alt="Add to Technorati"
                             title="Technorati" /><span class="soc-bm-link-text">Technorati</span></a></li>
                  <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/short/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=FACEBOOK"
                        class="sb-facebook"
                        rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                             title="Facebook" /><span class="soc-bm-link-text">Facebook</span></a></li>
                  <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                             title="Twitter" /><span class="soc-bm-link-text">Twitter</span></a></li>
               </ul>
               
               <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
               
            </div><span id="related-urls"></span><span id="patientinform-links"></span></div>
         <div id="col-2">
            
            <div class="article-nav">
               <a href="/content/58/9/e10.short" title="Previous article">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/58/9/1947.short" title="Next article">Next Article »</a><span class="toc-link"><a href="/content/58/9.toc" title="Table of Contents">Table of Contents</a></span>
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              
                              	    
                              
                              doi:
                              <span title="10.2337/db09-0451" class="slug-doi">10.2337/db09-0451
                                 </span>
                              <cite>
                                 	    <abbr title="Diabetes" class="slug-jnl-abbrev">
                                    Diabetes</abbr><span class="slug-pub-date">
                                    	    August 28, 2009 
                                    </span>
                                 	    <span class="slug-vol">
                                    vol. 58 
                                    </span><span class="slug-issue">
                                    no. 9 
                                    </span><span class="slug-pages">
                                    1939-1946
                                    </span>
                                 </cite>
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section">
                     <ol>
                        <li><a href="/content/58/9/1939.extract" rel="view-extract">Extract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text</span></span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/58/9/1939.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a></li>
                     </ol>
                  </div>
                  <div class="cb-section" id="cb-articleworks">
                     <ol>
                        <li><a href="/external-ref?link_type=ARTICLEWORKS&amp;action=buy&amp;reprint_url=http://diabetes.diabetesjournals.org/content/58/9/1939.full.pdf&amp;member=&amp;journal=diabetes&amp;volume=58&amp;issue_number=9&amp;cover_date=August%2028,%202009&amp;firstpage=1939&amp;pages=8&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes&amp;authors=Jide%20Tian,%20Daniel%20L.%20Kaufman">Purchase Article</a></li>
                        <li><a href="/external-ref?link_type=ARTICLEWORKS&amp;action=cart">View Shopping Cart</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li><a href="/email?gca=diabetes;58/9/1939&amp;current-view-path=/content/58/9/1939.full">
                              Email this article to a colleague</a></li>
                        <li><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=diabetes;58/9/1939&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://diabetes.diabetesjournals.org/content/58/9/1939.full">Alert me when this article is cited</a></li>
                        <li><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=58/9/1939&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://diabetes.diabetesjournals.org/content/58/9/1939.full">Alert me if a correction is posted</a></li>
                        <li><a href="/search?qbe=diabetes;58/9/1939&amp;citation=Tian%20and%20Kaufman%2058%20%289%29:%201939&amp;submit=yes">Similar articles in this journal</a></li>
                        <li><a href="/external-ref?access_num=19720821&amp;link_type=MED_NBRS">Similar articles in PubMed</a></li>
                        <li><a href="/citmgr?gca=diabetes;58/9/1939">Download to citation manager</a></li>
                        <li><a href="/external-ref?link_type=PERMISSIONDIRECT"><img src="/shared/img/content/permissions.gif" /></a></li>
                        <li><a href="/content/58/9/1939.full?patientinform-links=yes&amp;legid=diabetes;58/9/1939#patientinform-links"
                              id="cb-patientinform">Load <em>patient</em>INFORMation</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li><a href="/content/58/9/1939.full?cited-by=yes&amp;legid=diabetes;58/9/1939#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/external-ref?access_num=http://diabetes.diabetesjournals.org/cgi/content/full/58/9/1939&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li><a href="http://scholar.google.com/scholar?q=%22author%3ATian%20author%3AJ.%22">Articles by  Tian, J.</a></li>
                        <li><a href="http://scholar.google.com/scholar?q=%22author%3AKaufman%20author%3AD.L.%22">Articles by  Kaufman, D. L.</a></li>
                        <li><a href="/external-ref?access_num=http://diabetes.diabetesjournals.org/cgi/content/full/58/9/1939&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li><a href="/external-ref?access_num=19720821&amp;link_type=PUBMED">PubMed citation</a></li>
                        <li><a href="/external-ref?access_num=Tian%20J&amp;link_type=AUTHORSEARCH">Articles by  Tian, J.</a></li>
                        <li><a href="/external-ref?access_num=Kaufman%20DL&amp;link_type=AUTHORSEARCH">Articles by  Kaufman, D. L.</a></li>
                        <li>
                           <div id="cb-entrez-links-placeholder"><a href="/entrez-links/19720821"></a></div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Social Bookmarking</span></h4>
                     <ol>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /><span class="soc-bm-link-text">CiteULike</span></a></li>
                                 <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Del.icio.us"
                                            title="Del.icio.us" /><span class="soc-bm-link-text">Del.icio.us</span></a></li>
                                 <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=DIGG"><img src="/shared/img/common/social-bookmarking/digg.gif" alt="Add to Digg"
                                            title="Digg" /><span class="soc-bm-link-text">Digg</span></a></li>
                                 <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=REDDIT"><img src="/shared/img/common/social-bookmarking/reddit.gif" alt="Add to Reddit"
                                            title="Reddit" /><span class="soc-bm-link-text">Reddit</span></a></li>
                                 <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=TECHNORATI"><img src="/shared/img/common/social-bookmarking/technorati.gif"
                                            alt="Add to Technorati"
                                            title="Technorati" /><span class="soc-bm-link-text">Technorati</span></a></li>
                                 <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/short/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /><span class="soc-bm-link-text">Facebook</span></a></li>
                                 <li><a href="/external-ref?tag_url=http://diabetes.diabetesjournals.org/cgi/content/long/58/9/1939&amp;title=Antigen-Based%20Therapy%20for%20the%20Treatment%20of%20Type%201%20Diabetes+--+Tian%20and%20Kaufman%2058%20%289%29%3A%201939+--+Diabetes&amp;doi=10.2337/db09-0451&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /><span class="soc-bm-link-text">Twitter</span></a></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#sec-1"></a></li>
                        <li><a href="#ack-1">Acknowledgments</a></li>
                        <li><a href="#fn-group-1">Footnotes</a></li>
                        <li><a href="#ref-list-1">REFERENCES</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            			
            <div class="col-3-top sb-div"></div>
            			
            <div class="content-box" id="sidebar-current-issue">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Current Issue</span></h3>
                  <div class="cb-section">
                     <ol>
                        <li><span><a href="/content/current" rel="current-issue">April 2011, 60 (4)</a></span></li>
                     </ol>
                  </div>
                  <div class="cb-section">
                     <ol>
                        <div class="current-issue"><a href="/content/current" rel="current-issue"><img src="/local/img/cover.gif" width="67" height="89" alt="Current Issue" /></a></div>
                     </ol>
                  </div>
                  <div class="cb-section sidebar-etoc-link">
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues of Diabetes
                              </a></li>
                     </ol>
                  </div>
               </div>
            </div>
            <div id="sidebar-global-nav">
               
               
               <ul class="button-list pub-links">
                  <li class="first"><a href="/site/misc/ifora.xhtml" title="Instructions for Authors"><span>Instructions for Authors</span></a></li>
                  <li><a href="http://mc.manuscriptcentral.com/diabetes" rel="external-nw"
                        title="Manuscript Submissions"><span>Manuscript Submissions</span></a></li>
                  <li><a href="/site/misc/about.xhtml" title="About the Journal"><span>About the Journal</span></a></li>
                  <li><a href="/site/misc/edboard.xhtml" title="Editorial Board"><span>Editorial Board</span></a></li>
                  <li><a href="/site/subscriptions" title="Subscriptions"><span>Subscriptions</span></a></li>
                  <li><a href="/site/misc/PDA_services.xhtml" title="PDA Services"><span>PDA Services</span></a></li>
                  <li><a href="/site/misc/Adv_Reprints.xhtml" title="Advertising &amp; Reprints"><span>Advertising &amp; Reprints</span></a></li>
                  <li><a href="http://professional.diabetes.org/" rel="external-nw"
                        title="ADA's DiabetesPro"><span>ADA's DiabetesPro</span></a></li>
                  <li><a href="https://www.memberconnections.com/olc/pub/AMD/directory.html"
                        rel="external-nw"
                        title="ADA Member Directory"><span>ADA Member Directory</span></a></li>
                  <li><a href="/rss" title="RSS Feeds"><span>RSS Feeds</span></a></li>
                  <li class="last"><a href="/cgi/alerts/etoc" title="E-mail Alerts"><span>E-mail Alerts</span></a></li>
               </ul>
               
               
               
               <ul class="button-list pub-links other-jnl-links">
                  <li class="first"><a href="http://care.diabetesjournals.org/" title="Diabetes Care"><span>Diabetes Care</span></a></li>
                  <li><a href="http://clinical.diabetesjournals.org/" title="Clinical Diabetes"><span>Clinical Diabetes</span></a></li>
                  <li class="last"><a href="http://spectrum.diabetesjournals.org/" title="Diabetes Spectrum"><span>Diabetes Spectrum</span></a></li>
               </ul>
               
            </div>
            <ul class="tower-ads"><span class="ad-tower">
                  <a href="http://www.e-healthcaresolutions.com/advertising_contact.php"
                     target="_blank">Advertisement</a>
                  </span><li class="position-right1">
                  <script language="JavaScript" type="text/javascript">
          OAS_AD('Right');
        </script>
                  </li>
            </ul>
            <div id="sidebar-icon-group">
               <a href="http://www.diabetes.org/" rel="external-nw"><img src="/publisher/img/society_logo.gif" class="publisher-icon" alt="Society Logo" /></a>
               
               <a href="http://highwire.stanford.edu/" rel="external-nw"><img src="/shared/img/common/hplogo.gif" class="hw-icon" alt="Highwire Press Logo" /></a>
               
               
               
               
            </div>
            			
            			
            		
         </div>
         <div id="footer">
            
            <div class="block-1">
               
               <p class="copyright">Copyright © 2011 by the American Diabetes Association</p>
               
               <ul class="issns">
                  <li><span>Print ISSN: </span>
                     <span class="issn">0012-1797</span></li>
                  <li><span>Online ISSN: </span>
                     <span class="issn">1939-327X</span></li>
               </ul>
               
            </div>
            
            
            <div class="block-2 sb-div"></div>
            <script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        var pageTracker = _gat._getTracker("UA-1543923-1");
        pageTracker._trackPageview();
        </script>
            </div>
      </div>
   </body>
</html>
